Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review
Open Access
- 1 September 2016
- journal article
- case report
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (9) , 1725-1728
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Alternative donor hematopoietic cell transplantation for Fanconi anemiaBlood, 2015
- Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experienceBlood, 2013
- Haematopoietic cell transplantation for acute leukaemia and advanced myelodysplastic syndrome in Fanconi anaemiaBritish Journal of Haematology, 2013
- Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in childrenLeukemia, 2013
- Allogeneic Hematopoietic Cell Transplantation for Fanconi Anemia in Patients With Pretransplantation Cytogenetic Abnormalities, Myelodysplastic Syndrome, or Acute LeukemiaJournal of Clinical Oncology, 2013
- Fludarabine‐based cytoreductive regimen and T‐cell‐depleted grafts from alternative donors for the treatment of high‐risk patients with Fanconi anaemiaBritish Journal of Haematology, 2008
- In Vitro Effect of Fludarabine, Cyclophosphamide, and Cytosine Arabinoside on Chromosome Breakage in Fanconi Anemia Patients: Relevance to Stem Cell TransplantationInternational Journal of Hematology, 2007
- Natural pregnancy and delivery after allogeneic bone marrow transplantation in a Fanconi anaemia patientBritish Journal of Haematology, 2006
- Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low‐dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemiaBritish Journal of Haematology, 2006
- Sequential Regimen of Chemotherapy, Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation, and Prophylactic Donor Lymphocyte Transfusion in High-Risk Acute Myeloid Leukemia and Myelodysplastic SyndromeJournal of Clinical Oncology, 2005